Volume | 43,464 |
|
|||||
News | - | ||||||
Day High | 0.6695 | Low High |
|||||
Day Low | 0.60 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Trevena Inc | TRVN | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.60 | 0.60 | 0.6695 | 0.6132 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
87 | 43,464 | $ 0.6384685 | $ 27,750 | - | 0.5084 - 3.28 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
09:42:27 | 100 | $ 0.66925 | USD |
Trevena Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
9.26M | 15.17M | - | -418k | -53.67M | -3.54 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Trevena News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TRVN Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.58 | 0.6695 | 0.54 | 0.5928885 | 149,982 | 0.08925 | 15.39% |
1 Month | 0.5784 | 0.6695 | 0.5084 | 0.585669 | 89,831 | 0.09085 | 15.71% |
3 Months | 0.7015 | 1.03 | 0.5084 | 0.6184369 | 353,011 | -0.03225 | -4.6% |
6 Months | 1.00 | 1.12 | 0.5084 | 0.8511864 | 503,661 | -0.33075 | -33.08% |
1 Year | 3.06 | 3.28 | 0.5084 | 2.02 | 973,721 | -2.39 | -78.13% |
3 Years | 58.00 | 77.50 | 0.5084 | 28.21 | 1,573,239 | -57.33 | -98.85% |
5 Years | 16.15 | 112.50 | 0.5084 | 39.40 | 2,146,036 | -15.48 | -95.86% |
Trevena Description
Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain. |